## Baseline Assessment and Monitoring in Lepromatous Leprosy **Key Point:** Slit-skin smear with AFB grading (Bacterial Index) is the standard, practical investigation for establishing baseline bacterial load in lepromatous leprosy and monitoring response to MDT during and after treatment. ### Bacterial Index (BI) Grading The slit-skin smear is performed from 6 standard sites (earlobes, cheeks, chin, forearms, thighs, shins) and AFB are counted and graded: **High-Yield:** BI is reported on a logarithmic scale (0 to 6+): - BI 0 = No AFB seen - BI 1–2 = Few AFB - BI 3–4 = Moderate AFB (typical in BL leprosy) - BI 5–6 = Numerous AFB (typical in LL leprosy) ### Role in MDT Monitoring | Timepoint | BI Significance | |---|---| | **Baseline** | Establishes bacterial load; confirms lepromatous type | | **6 months (end of MDT)** | Should show ≥2-log reduction | | **12–24 months post-MDT** | BI may remain positive but bacilli are non-viable (morphological index) | **Clinical Pearl:** A negative lepromin test + high BI (3–4+) in a patient with diffuse skin lesions and nodules confirms BL leprosy. The BI is repeated at 6 months and 12 months post-MDT to confirm bacteriological cure (morphological index <5% viable bacilli). ### Why Other Investigations Are Not First-Line | Investigation | Limitation | |---|---| | Lepromin test at 3 months | Does not change during treatment; used only for baseline classification | | PCR for M. leprae DNA | Expensive, not routine; detects DNA but not viability; not available in most centers | | Anti-PGL-I antibodies | Useful for epidemiological surveys; does not guide individual patient management or monitor treatment response | **Mnemonic:** **BI-BEST** = Bacterial Index is the Best, Essential, Standard Test for lepromatous leprosy monitoring. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.